Picture of Moderna logo

MRNA — Moderna Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapContrarian

Momentum

Relative Strength (%)
1m+2.21%
3m+3.16%
6m-38%
1yr-12.55%
Volume Change (%)
10d/3m-9.71%
Price vs... (%)
52w High-72.61%
50d MA-11.69%
200d MA-45.91%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)6.66
PEG Ratio (f)n/a
EPS Growth (f)-27.3%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value3.17
Price to Tang. Book3.17
Price to Free Cashflow4.16
Price to Sales2.4
EV to EBITDA2.71

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital88.49%
Return on Equity139.99%
Operating Margin71.93%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m205.82135.0760.21803.3918,47121,994.0810,379.31179.44%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/an/an/a-1.63-68.75n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for MRNA

After a strong run, what's next for investors in Moderna Inc? background image

After a strong run, what's next for investors in Moderna Inc?

If you've ever found yourself feeling increasingly drawn to a stock that's constantly rising in price, you are not alone...  Since the dawn of the stock market, speculators have been captured by the tendency of prices to 'trend'.  When...

Will Moderna Inc's price keep soaring? background image

Will Moderna Inc's price keep soaring?

Studies by leading experts into the power of price momentum show that stocks with the strongest price trends tend to keep up the pace for anywhere up to one year. A big part of the reason for this is down to investor psychology.  With...

Recent price trends point to good news for Moderna Inc shares background image

Recent price trends point to good news for Moderna Inc shares

Shares in Moderna Inc (NSQ:MRNA) have been on a solid run over the past year - and that should be good news for investors wondering where the price will move next. As you can see, in terms of relative price strength the stock has been...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Moderna EPS forecast chart

Profile Summary

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The Company develops technologies that enable the development of mRNA medicines for diverse applications. It has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The Company develops technologies that enable the development of mRNA medicines.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
July 22nd, 2016
Public Since
December 7th, 2018
No. of Shareholders
85
No. of Employees
2,700
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
397,759,517

MRNA Share Price Performance

Latest News for MRNA

Upcoming Events for MRNA

Moderna Inc at UBS Global Healthcare Conference

Q2 2022 Moderna Inc Earnings Release

Q3 2022 Moderna Inc Earnings Release

Similar to MRNA

Picture of 2Seventy Bio logo

2Seventy Bio

us flag iconNASDAQ Global Select Market

Picture of 4D Molecular Therapeutics logo

4D Molecular Therapeutics

us flag iconNASDAQ Global Select Market

Picture of AbCellera Biologics logo

AbCellera Biologics

us flag iconNASDAQ Global Select Market

Picture of AbSci logo

AbSci

us flag iconNASDAQ Global Select Market

Picture of ACADIA Pharmaceuticals logo

ACADIA Pharmaceuticals

us flag iconNASDAQ Global Select Market

FAQ

Or unlock with your email

Or unlock with your email